The Belgian Society of Nuclear Medicine (BSNM, nowadays called ‘BELNUC’) was founded in 1978 by physicians who had previously been involved in an extended partnership with radiation therapy and radiology. The first president was Michel De Roo from the Katholieke Universiteit Leuven. Nuclear medicine had been practiced in Belgium since the late 1940s and progressively developed as a separate specialty, first in university institutes and later, from the 1970s onwards, in many hospitals. The development of PET scanning began in the early 1980s, purely as a research endeavour.
Alzheimer’s neurodegenerative conditions
Learn how Alzheimer’s disease affects the brain and which symptoms may appear over time. This article explains the diagnostic process and how nuclear medicine imaging supports early detection and clinical decision-making. It also outlines what patients and families can expect during evaluation and follow-up care.
Welcome to the section
The Belgian Society of Nuclear Medicine (BSNM, nowadays called ‘BELNUC’) was founded in 1978 by physicians who had previously been involved in an extended partnership with radiation therapy and radiology. The first president was Michel De Roo from the Katholieke Universiteit Leuven. Nuclear medicine had been practiced in Belgium since the late 1940s and progressively developed as a separate specialty, first in university institutes and later, from the 1970s onwards, in many hospitals. The development of PET scanning began in the early 1980s, purely as a research endeavour.
The Belgian Society of Nuclear Medicine (BSNM, nowadays called ‘BELNUC’) was founded in 1978 by physicians who had previously been involved in an extended partnership with radiation therapy and radiology. The first president was Michel De Roo from the Katholieke Universiteit Leuven. Nuclear medicine had been practiced in Belgium since the late 1940s and progressively developed as a separate specialty, first in university institutes and later, from the 1970s onwards, in many hospitals.
